Uploaded April 2026 | Updated September 2026, 1 hour ago
GLP-1 medications like semaglutide have been widely discussed as breakthrough treatments for weight loss and metabolic health. But a large new study published in The Lancet Psychiatry is shifting the conversation toward something deeper: the connection between metabolic health and mental health.
In this video, Dr. Bret Scher breaks down what the research actually shows, and just as importantly, what it doesn’t.
The study analyzed health records from over 95,000 individuals with type 2 diabetes and depression or anxiety. Those taking GLP-1 medications showed a lower risk of severe psychiatric outcomes, including hospitalization and self-harm, compared to other diabetes treatments.
But here’s the nuance:
This wasn’t an intervention trial, and it didn’t show that GLP-1s treat depression or lead to remission. Instead, it showed less worsening of mental health over time.
This video explores:
- What “less worsening” really means in mental health research
- Why metabolic health and brain health are closely connected
- The limitations of large observational studies
- How GLP-1s might fit into a broader metabolic approach to mental health
- The emerging role of ketogenic therapy and other metabolic interventions
👉 To learn more about responsible use and clinical considerations for GLP-1 medications, explore the Coalition for Metabolic Health’s policy brief on GLP-1s: coalitionformetabolichealth.org/resources/glp-1-medications-and-metabolic-health
🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.
#MetabolicMind #CoalitionForMetabolicHealth #KetogenicTherapy
*Expert Featured:*
- Dr. Bret Scher
- Baszucki Group Medical Director
- https://x.com/bschermd
*Resources Mentioned:*
- Coalition for Metabolic Health’s policy brief on GLP-1s: coalitionformetabolichealth.org/resources/glp-1-medications-and-metabolic-health/)
*Free CME Clinician Trainings:*
Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.
Our courses have been made *FREE* by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits:
metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-yt
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org
*About us:*
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
*Timestamps:*
0:00 - GLP-1s & Mental Health: Do They Treat Depression & Anxiety?
0:21 - 95,000 Patient Study: GLP-1s vs Other Diabetes Meds
1:26 - Key Finding: Less Worsening of Mental Health (Not a Treatment or Cure)
2:21 - What’s Missing: No Data on Weight Loss or Metabolic Health
2:55 - Keto vs GLP-1s: Metabolic Health & Mental Health Connection
3:39 - Using The Two Together: Coalition for Metabolic Health Position Statement
GLP-1 medications like semaglutide have been widely discussed as breakthrough treatments for weight loss and metabolic health. But a large new study published in The Lancet Psychiatry is shifting the conversation toward something deeper: the connection between metabolic health and mental health.
In this video, Dr. Bret Scher breaks down what the research actually shows, and just as importantly, what it doesn’t.
The study analyzed health records from over 95,000 individuals with type 2 diabetes and depression or anxiety. Those taking GLP-1 medications showed a lower risk of severe psychiatric outcomes, including hospitalization and self-harm, compared to other diabetes treatments.
But here’s the nuance:
This wasn’t an intervention trial, and it didn’t show that GLP-1s treat depression or lead to remission. Instead, it showed less worsening of mental health over time.
This video explores:
- What “less worsening” really means in mental health research
- Why metabolic health and brain health are closely connected
- The limitations of large observational studies
- How GLP-1s might fit into a broader metabolic approach to mental health
- The emerging role of ketogenic therapy and other metabolic interventions
👉 To learn more about responsible use and clinical considerations for GLP-1 medications, explore the Coalition for Metabolic Health’s policy brief on GLP-1s: coalitionformetabolichealth.org/resources/glp-1-medications-and-metabolic-health
🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.
#MetabolicMind #CoalitionForMetabolicHealth #KetogenicTherapy
*Expert Featured:*
- Dr. Bret Scher
- Baszucki Group Medical Director
- https://x.com/bschermd
*Resources Mentioned:*
- Coalition for Metabolic Health’s policy brief on GLP-1s: coalitionformetabolichealth.org/resources/glp-1-medications-and-metabolic-health/)
*Free CME Clinician Trainings:*
Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.
Our courses have been made *FREE* by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits:
metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-yt
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org
*About us:*
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
*Timestamps:*
0:00 - GLP-1s & Mental Health: Do They Treat Depression & Anxiety?
0:21 - 95,000 Patient Study: GLP-1s vs Other Diabetes Meds
1:26 - Key Finding: Less Worsening of Mental Health (Not a Treatment or Cure)
2:21 - What’s Missing: No Data on Weight Loss or Metabolic Health
2:55 - Keto vs GLP-1s: Metabolic Health & Mental Health Connection
3:39 - Using The Two Together: Coalition for Metabolic Health Position Statement
